# A Study of GNTI-122 in Adults Recently Diagnosed With T1D

> **NCT06919354** · PHASE1 · RECRUITING · sponsor: **GentiBio, Inc** · enrollment: 16 (estimated)

## Conditions studied

- Type 1 Diabetes (T1D)
- Type 1 Diabetes Mellitus

## Interventions

- **BIOLOGICAL:** GNTI-122

## Key facts

- **NCT ID:** NCT06919354
- **Lead sponsor:** GentiBio, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-03
- **Primary completion:** 2028-02
- **Final completion:** 2028-02
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2026-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06919354

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06919354, "A Study of GNTI-122 in Adults Recently Diagnosed With T1D". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06919354. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*